ADVIA CENTAUR XP AFP ASSAY N/A 10309980

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional,user faci report with the FDA on 2018-06-05 for ADVIA CENTAUR XP AFP ASSAY N/A 10309980 manufactured by Siemens Healthcare Diagnostics, Inc..

Event Text Entries

[110172410] A siemens field service engineer (fse) was sent to the customer site for system inspection. The fse verified good wash block function. The fse made adjustments to the reagent probe 1 calibration. The customer replaced the afp reagent and ran all quality control (qc). The qc passed. The customer ran afp x5 on 4 patients. Precision is good. The customer confirmed afp is functioning properly on the analyzer. The customer had a sample that recovered 1. 9 ng/ml when originally tested with advia centaur xp alpha-fetoprotein (afp) lot 193 but 3. 0 ng/ml when retested. Two other samples showed similar differences. Siemens does not have any precision claims for the advia centaur xp afp assay with samples < 16. 5 ng/ml. The values for the samples are well within the normal range (0 - 8. 0 ng/ml) listed in the advia centaur xp afp instructions for use (ifu) so there is no change in clinical interpretation. The cause of the difference in the values cannot be determined but there is no indication it is abnormal performance. Based on the available information advia centaur xp alpha-fetoprotein (afp) lot 193 is performing as intended. The instrument is performing within specifications. No further evaluation of the device is required. The ifu states in the interpretation of results section: "results of this assay should always be interpreted in conjunction with patient's medical history, clinical presentation and other findings. "
Patient Sequence No: 1, Text Type: N, H10


[110172411] A low advia centaur xp afp result was obtained for a patient sample. The customer repeats any sample with a result less than three. The patient sample was repeated and the result was higher. The initial result was reported to the physician and was not questioned. Patient treatment was not prescribed or altered. There was no report of adverse health consequences due to the discordant afp result.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1219913-2018-00163
MDR Report Key7568996
Report SourceHEALTH PROFESSIONAL,USER FACI
Date Received2018-06-05
Date of Report2018-06-05
Date of Event2018-05-18
Date Mfgr Received2018-05-18
Date Added to Maude2018-06-05
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. EIMAN SULIEMAN
Manufacturer Street333 CONEY STREET
Manufacturer CityE. WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal02032
Manufacturer Phone5086604603
Manufacturer G1SIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer Street333 CONEY STREET
Manufacturer CityE. WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal Code02032
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameADVIA CENTAUR XP AFP ASSAY
Generic NameAFP IMMUNOASSAY
Product CodeLOJ
Date Received2018-06-05
Model NumberN/A
Catalog Number10309980
Lot Number48772193
Device Expiration Date2018-11-17
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer Address511 BENEDICT AVENUE TARRYTOWN NY 105915097 US 105915097


Patients

Patient NumberTreatmentOutcomeDate
10 2018-06-05

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.